Sodium salicylate-induced apoptosis of human peripheral blood eosinophils is independent of the activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase

International Archives of Allergy and Immunology

Volumn 121, Issue 1, 2000, Pages 44-52

  Wong, C K ^a   Zhang, J P ^a   Lam, C W K ^a   Ho, C Y ^a   Hjelm, N M ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; c Jun N terminal kinase; Eosinophils; Extracellular signal regulated protein kinase; p38 mitogen activated protein kinase; Sodium salicylate

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PROTEIN C JUN; SALICYLATE SODIUM;

APOPTOSIS; ARTICLE; ASSAY; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; EOSINOPHIL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL;

EID: 0033953616     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024296     Document Type: Article

References (45)

1. Sly RM: Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol 1999;82:233-248.
2. Weller PF: The immunobiology of eosinophils. N Engl J Med 1991;324:1110-1118.
3. Mehta H, Busse WW: Eosinophils as a therapeutic target in allergic disease. Compr Ther 1994;20:651-657.
4. Spry O, Kay AB, Gleich GJ: Eosinophils. Immunol Today 1992;13:384-387.
5. Gleich GJ: The eosinophil and bronchial asthma: Current understanding. J Allergy Clin Immunol 1990;85:422-436.
6. Tai PC, Sun L, Spry CJF: Effect of IL-5, granulocyte/macrophages colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin Exp Immunol 1991;85:312-316.
7. Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K: Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:3902-3908.
8. Wedi B: Delayed eosinophil programmed cell death in vitro: A common feature of inhalant allergy and extrinsic and intrinsinc atopic dermatitis. J Allergy Clin Immunol 1997;100: 536-543.
9. Yousefi S, Blaser K, Simon HU: Activation of signaling pathways and prevention of apoptosis by cytokines in eosinophils. Int Arch Allergy Immunol 1997;112:9-12.
10. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326-1331.
11. Maroney AC, Glicksman MA, Basma AN, Walton KM, Knight E, Murphy CA, Bartlett BA, Finn JP, Angeles T, Matsuda Y, Neff NT, Ionne CA: Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J Neurosci 1998;18: 104-111.
12. Frasch SC, Nick JA, Fadok VA, Bratton DL, Worthen GS, Henson PM: p38 Mitogen-activated protein kinase-dependent and independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J Biol Chem 1998;273:8389-8397.
13. Yousefi S, Hoessli DC, Blaser K, Mills GB, Simon HU: Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J Exp Med 1996;183:1407-1414.
14. Bruggen TVD, Koenderman L: Signal transduction in eosinophils. Clin Exp Allergy 1996; 26:880-891.
15. Bracke M, Coffer PJ, Lammers JWJ, Koenderman L: Analysis of signal transduction pathways regulating cytokine-mediated Fc receptor activation on human eosinophils. J Immunol 1998;161:6768-6774.
16. Cobb MH, Goldsmith EJ: How MAP kinases are regulated. J Biol Chem 1995;270:14843-14846.
17. Marshall CJ: Specificity of receptor tyrosine kinase signaling transient versus sustained extracellular signal-regulated kinase activation. Cell 1995;80:179-185.
18. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ: JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994;76:1025-1037.
19. Vietor I, Schwenger P, Li W, Schlessinger J, Vilcek J: Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts. J Biol Chem 1993;268: 18994-18999.
20. Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, Kyriakis JM, Zon LI: Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 1994;372:794-798.
21. Schwenger P, Skolink EY, Vilcek J: Inhibition of tumor necrosis factor-induced p42/44 mitogen-activated protein kinase by sodium salicylate. J Biol Chem 1996;271:8089-8094.
22. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Davis RJ: Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 1996;15:2760-2770.
23. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, Young PR: Novel homologues of CSBP/p38 MAP kinase: Activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 1997;235:533-538.
24. Li Z, Jiang Y, Ulevitch RJ, Han J: The primary structure of p38 gamma: A new member of the p38 group of MAP kinases. Biochem Biophys Res Commun 1996;228:334-340.
25. Schwenger P, Bellosta P, Vietor I, Basilico C, Skolnik EY, Vilcek J: Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci USA 1997;94:2869-2873.
26. Schwenger P, Alpert D, Skolnik EY, Vilcek J: Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced 1kappaB alpha phosphorylation and degradation. Mol Cell Biol 1998;18:78-84.
27. Berra E, Diaz-Meco MT, Moscat J: The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J Biol Chem 1998;273: 10792-10797.
28. Walsh GM, Dewson G, Wardlaw AJ, Levi-Schaffer F, Moqbel R: A comparative study of different methods for the assessment of apoptosis and necrosis in human eosinophils. J Immunol Methods 1998;217:153-163.
29. Hii CSR, Huang ZH, Bilney A, Costabile M, Murray AW, Rathjen DA, Der CJ, Ferrante A: Stimulation of p38 phosphorylation and activity by arachidonic acid in HeLa cells. HL60 promyelocytic leukemic cells, and human neutrophils. J Biol Chem 1998;273:19277-19282.
30. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TE, Young PP, Lee JC: SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995;364:229-233.
31. Elder DJE, Hague A, Hicks DJ, Paraskeva C: Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: Enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res 1996;56: 2273-2276.
32. Wong CK, Zhang JP, Lam CWK, Ho CY, Hjelm NM: Opposing effects of sodium salicylate and haematopoietic cytokines IL-3, IL-5 and GM-CSF on mitogen-activated protein kinases and apoptosis of EoL-1 cells. Immunol Invest, in press.
33. Bates ME, Bertics PJ, Busse WW: IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils. J Immunol 1996;156:711-718.
34. Graves JD, Draves KE, Craxton A, Saklatvala J, Krebs EG, Clark EA: Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes. Proc Natl Acad Sci USA 1996;93:13814-13818.
35. Kawasaki H, Morooka T, Shimohama S, Kimura J, Hirano T, Gotoh Y, Nishida E: Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J Biol Chem 1997;272:18518-18521.
36. Kinoshita T, Yokota T, Arai K, Miyajima A: Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors. EMBO J 1995;14:266-275.
37. Nemoto S, Xiang J, Huang S, Lin A: Induction of apoptosis by SB202190 through inhibition of p38β mitogen-activated protein kinase. J Biol Chem 1998;273:16415-16420.
38. Pazdrak K, Schreiber D, Forsythe P, Justement L, Alam R: The intracellular signal transduction mechanism of interleukin 5 in eosinophils: The involvement of Lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway. J Exp Med 1995;181: 1827-1834.
39. Hiraguri M, Miike S, Sano H, Kurasawa K, Saito Y, Iwamoto I: Granulocyte-macrophage colony-stimulating factor and IL-5 activate mitogen-activated protein kinase through Jak2 kinase and phosphatidylinositol 3-kinase in human eosinophils. J Allergy Clin Immunol 1997; 100:S45-S51.
40. Pazdrak K, Pazdrak BO, Stafford S, Garofalo RP, Alam R: Lyn, Jak2 and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation. J Exp Med 1998;188:421-429.
41. Callsen D, Brüne B: Role of mitogen-activated protein kinases in S-nitrosoglutathione-induced macrophage apoptosis. Biochemistry 1999;38:2279-2286.
42. Schleimer RP, Bochner BS: The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol 1994;94:1202-1213.
43. Hofmann TG, Hehner SP, Bacher S, Dröge W, Schmitz ML: Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NF-κB-dependent transcription.FEBS Lett 1998;441:441-446.
44. Wang W, Wykrzykowska J, Johnson T, Sen R, Sen J: A NF-κB/c-myc-dependent survival pathway is targeted by corticosteroids in immature thymocytes. J Immunol 1999;162:314-322.
45. Adachi T, Motojima S, Hirata A, Fukuda T, Kihara N, Kosaku N, Ohtake H, Makino S: Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5. J Allergy Clin Immunol 1996; 98:S207-S215.